Skip to content

Carevent CA and DRA

by O-Two Medical Technologies Inc

510(k) K051889

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK051889 Date30 Aug 2005ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
BTL
FDA applicant
O-Two Medical Technologies, Inc.
Device class
Class II
Regulation
21 CFR Part 868.5925
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Carevent CA and DRA is an emergency powered resuscitator (ventilator) designed for use in hazardous chemical agent environments. It provides automatic ventilation with minimal rescuer intervention, ensuring rapid and effective patient resuscitation in life-threatening situations. This device is classified as a Class II medical device and is intended for use in scenarios requiring immediate respiratory support under hazardous conditions.

Supplied as a reusable medical device, the Carevent CA and DRA is intended for use in emergency settings where chemical agents or immediately dangerous to life and health (IDLH) environments are present. It requires connection to an oxygen/air supply and features a single external control for operation. The device has received FDA 510(k) clearance under Special Review with a classification under regulation number 868.5925, and is regulated under the Anesthesiology advisory committee category. No third-party review was required.

Other devices from O-Two Medical Technologies Inc

See all devices from O-Two Medical Technologies Inc →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Carevent CA and DRA designed for?

    The Carevent CA and DRA is an emergency powered resuscitator specifically designed for use in hazardous chemical agent environments, where immediate respiratory support is critical. It provides automatic ventilation with minimal rescuer intervention, ensuring rapid and effective patient resuscitation in life-threatening situations involving chemical agents or immediately dangerous to life and health (IDLH) conditions.

  • Is the Carevent CA and DRA a single-use or reusable device?

    The Carevent CA and DRA is supplied as a reusable medical device. This classification allows for repeated use in emergency settings, provided proper maintenance and cleaning protocols are followed to ensure safety and functionality.

  • What power source or supply does the Carevent CA and DRA require?

    The Carevent CA and DRA requires connection to an external oxygen/air supply to operate. This ensures reliable ventilation support in hazardous environments where other power sources may be unreliable or unavailable.

  • How is the Carevent CA and DRA controlled during use?

    The device features a single external control for operation, simplifying its use in emergency scenarios. This design minimizes rescuer fatigue and reduces the risk of errors during critical resuscitation efforts.

  • What regulatory pathway was followed for the Carevent CA and DRA?

    The Carevent CA and DRA received FDA 510(k) clearance under Special Review, classified under regulation number 868.5925 and regulated under the Anesthesiology advisory committee category. No third-party review was required for this clearance.